Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV is a research paper published in Nature Medicine (2019). On theSindex it has a DataRank of 0.729. It has been cited 128 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.729
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →European Commission
Grant: 639961
Antibody-Mediated Therapy of HIV-1 Infection
FWCI
11.31
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 2 of Characterization of B cell receptor H-CDR3 repertoire of spleen in PRV-infected mice
Additional file 1 of Characterization of B cell receptor H-CDR3 repertoire of spleen in PRV-infected mice
Additional file 2 of Characterization of B cell receptor H-CDR3 repertoire of spleen in PRV-infected mice
Additional file 1 of Characterization of B cell receptor H-CDR3 repertoire of spleen in PRV-infected mice